121 related articles for article (PubMed ID: 3895828)
1. The duration of oral anticoagulation after deep vein thrombosis. A randomized study.
Schulman S; Lockner D; Juhlin-Dannfelt A
Acta Med Scand; 1985; 217(5):547-52. PubMed ID: 3895828
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.
Pinede L; Ninet J; Duhaut P; Chabaud S; Demolombe-Rague S; Durieu I; Nony P; Sanson C; Boissel JP;
Circulation; 2001 May; 103(20):2453-60. PubMed ID: 11369685
[TBL] [Abstract][Full Text] [Related]
3. Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation.
Astermark J; Björgell O; Lindén E; Lethagen S; Nilsson P; Berntorp E
J Intern Med; 1998 Jul; 244(1):79-82. PubMed ID: 9698028
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.
Campbell IA; Bentley DP; Prescott RJ; Routledge PA; Shetty HG; Williamson IJ
BMJ; 2007 Mar; 334(7595):674. PubMed ID: 17289685
[TBL] [Abstract][Full Text] [Related]
5. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
[TBL] [Abstract][Full Text] [Related]
6. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
[TBL] [Abstract][Full Text] [Related]
7. Intensive initial oral anticoagulation and shorter heparin treatment in deep vein thrombosis.
Schulman S; Lockner D; Bergström K; Blombäck M
Thromb Haemost; 1984 Dec; 52(3):276-80. PubMed ID: 6397871
[TBL] [Abstract][Full Text] [Related]
8. A prospective controlled study of the efficacy of short-term anticoagulation therapy in patients with deep vein thrombosis of the lower extremity.
AbuRahma AF; Stickler DL; Robinson PA
J Vasc Surg; 1998 Oct; 28(4):630-7. PubMed ID: 9786257
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
[TBL] [Abstract][Full Text] [Related]
10. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.
Prandoni P; Prins MH; Lensing AW; Ghirarduzzi A; Ageno W; Imberti D; Scannapieco G; Ambrosio GB; Pesavento R; Cuppini S; Quintavalla R; Agnelli G;
Ann Intern Med; 2009 May; 150(9):577-85. PubMed ID: 19414836
[TBL] [Abstract][Full Text] [Related]
11. Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs.
Bounameaux H; de Moerloose P; Sarasin FP
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):507-14. PubMed ID: 8874860
[TBL] [Abstract][Full Text] [Related]
12. Studies on the medical treatment of deep vein thrombosis.
Schulman S
Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
[TBL] [Abstract][Full Text] [Related]
13. [Duration of oral anticoagulant therapy in deep venous thrombosis of the lower limbs].
Pinède L
Ann Cardiol Angeiol (Paris); 2002 Jun; 51(3):158-63. PubMed ID: 12471647
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of the extension of distal deep venous thrombosis. A randomized controlled trial with a 6-month follow-up].
Belcaro G; Laurora G; Cesarone MR; De Sanctis MT; Incandela L; Dugall M; Mezzanotte L
Minerva Med; 1997 Dec; 88(12):507-14. PubMed ID: 9540780
[TBL] [Abstract][Full Text] [Related]
15. Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis.
Sarasin FP; Bounameaux H
BMJ; 1998 Jan; 316(7125):95-9. PubMed ID: 9462312
[TBL] [Abstract][Full Text] [Related]
16. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.
Schulman S; Rhedin AS; Lindmarker P; Carlsson A; Lärfars G; Nicol P; Loogna E; Svensson E; Ljungberg B; Walter H
N Engl J Med; 1995 Jun; 332(25):1661-5. PubMed ID: 7760866
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
Jørgensen M; Broholm R; Bækgaard N
Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
[TBL] [Abstract][Full Text] [Related]
18. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
[TBL] [Abstract][Full Text] [Related]
19. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
[TBL] [Abstract][Full Text] [Related]
20. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society.
Lancet; 1992 Oct; 340(8824):873-6. PubMed ID: 1357297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
